Alderaan Biotechnology logo

Alderaan Biotechnology

A preclinical stage biotech company developing novel therapies to treat cancer by targeting cells from the immune system

3 employees · est. 2017 · Paris, France

VS
DustPhotonics logo

DustPhotonics

Enabling optical communication with silicon photonics end-to-end solutions.

73 employees · est. 2017 · Modi'in, Israel

DustPhotonics is the larger of the two.

Side-by-Side Comparison

Alderaan Biotechnology DustPhotonics
Founded
2017 2017
Headquarters
Paris, France Modi'in, Israel
Employees
3 73 larger
Industry
Biotechnology Data Analytics, Manufacturing, Telecom
Funding Stage
Series A Series B
Total Funding
$20.00M $85.00M
Funding Rounds
2 4
Services
Not tracked yet Transmit Photonics IC Development, Silicon Photonics Technology Platform, Laser Integration Solutions, Comprehensive Technology Library
Target Customers
Not tracked yet Data Centers, AI Platforms, High Bandwidth Applications, Optical Communication Market, Technology Integrators
Taxonomy
Immunotherapy, Oncology, Biopharmaceuticals, Monoclonal Antibodies, Treg Depletion, Cancer Therapy, Immunomodulation, Preclinical Research, Immunological Targets, NK Cell Targeting Silicon Photonics, Optical Communication, Pluggable Optical Modules, High Data Rates, Low Power Solutions, Cost Efficiency, High-Volume Scalability, Data Center Solutions, Enterprise Connectivity, HPC Applications, AuraDP Technology, Next-Generation Optical Modules, Connectivity Solutions, Supply Chain Partnerships, Technology Platform
Website
alderaan-biotechnology.com dustphotonics.com
Alderaan Biotechnology logo

About Alderaan Biotechnology

Alderaan Biotechnology, founded in 2017 and headquartered in Paris, France, is a preclinical stage biotech focused on developing novel cancer therapies by targeting immune cells. Their core expertise lies in immunomodulation and immunotherapy, particularly through the development of monoclonal antib...

DustPhotonics logo

About DustPhotonics

DustPhotonics, founded in 2017, is at the forefront of the Silicon Photonics revolution, providing end-to-end solutions that are crucial for enhancing optical communication. With a strong emphasis on enabling high data rates, reducing power consumption, and achieving cost-effective scalability, the...

We will tell you when either one moves

BounceWatch watches Alderaan Biotechnology and DustPhotonics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Alderaan Biotechnology and DustPhotonics — by email.

Frequently Asked Questions

Alderaan Biotechnology — A preclinical stage biotech company developing novel therapies to treat cancer by targeting cells from the immune system. DustPhotonics — Enabling optical communication with silicon photonics end-to-end solutions.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Alderaan Biotechnology has raised $20.00M while DustPhotonics has raised $85.00M.
Alderaan Biotechnology and DustPhotonics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Alderaan Biotechnology with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Alderaan Biotechnology on 7 Jun 2025, and DustPhotonics on 1 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes